Related by context. All words. (Click for frequent words.) 64 Partnering Agreements 60 Receives Tentative Approval 60 Gives Cautious 59 Partnering Guide 59 PharmaVitae Profile 58 Osteoporosis Drug 58 Ltd Therapeutic Competitors 58 Gout Drug 58 Arthritis Drug 58 Therapeutic Competitors Report 58 Drug Maker 57 ots.CorporateNews 57 Anemia Drug 57 Announces Tentative Approval 57 Preclinical Development 57 Receives Milestone Payment 57 Files IND 57 Announce Collaboration Agreement 56 Licensing Agreements 56 GlaxoSmithKline Sanofi Aventis 56 Extends Collaboration 56 Provides Detailed 56 Schizophrenia Drug 56 Bio Pharmaceutical 56 Psoriasis Drug 56 Patient Enrollment 56 www.novartis.com 56 Rheumatoid Arthritis Drug 56 First Patient Treated 56 Sanofi Aventis Novartis 55 http:/www.roche.com 55 Lung Cancer Drug 55 Drug Fails 55 Receives Approvable Letter 55 Nitec Pharma 55 Ondansetron Orally Disintegrating Tablets 55 Lupus Drug 55 Broadens Its 55 Pharmaceutical Excipients 55 Investigational Compound 55 Clinical Trial Enrollment 55 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 55 Tibotec BVBA 55 Gene Expression Analysis 55 Presents Positive Preclinical 55 Initiates Enrollment 55 RNA Therapeutics 55 Migraine Drug 55 Receives Marketing Authorization 55 Boosts Profit 55 Weight Loss Drug 55 Cholesterol Drug 55 Renal Cancer 55 Presents Positive 55 Inc. dba Vitro 54 Submits NDA 54 Regulatory Submissions 54 Initiates Clinical 54 Biotech Firm 54 Generic Versions 54 SWX RO SWX ROG 54 Gene Expression Profiling 54 Enteral Feed Devices 54 Biopharmaceutical Industry 54 Clinical Trial Results 54 Initiates Phase III 54 Cancer Vaccines 54 Anti Infectives 54 Settle Patent Litigation 54 Therapeutic Competitors companiesandmarkets.com adEgemonye 54 Inc Therapeutic Competitors 54 www.telit.com 54 Personalised Medicine 54 Kiadis 54 Generic Version 54 Successfully Completes Phase 54 Anti Infective 54 RNAi Therapeutics 54 Drug Shows Promise 54 Broadens Scope 54 Inflammatory Disease 53 Completes Patient Enrollment 53 Receives Orphan Drug 53 HCV Protease Inhibitor 53 Oncology Compounds 53 Molecular Diagnostic Test 53 Begins Shipment 53 Liver Transplant Patients 53 J.P. Morgan Healthcare 53 GlaxoSmithKline MedImmune 53 Prostate Cancer Vaccine 53 Seasonal Influenza Vaccine 53 EU# Mln 53 etamp 53 Endoscopy Laparoscopy 53 Cardiovascular Monitoring 53 QUMAS DocCompliance 53 Generic Protonix 53 Chugai Pharma 53 Sees Steady 53 Astex Therapeutics 53 - Aarkstore Enterprise [002] 53 Gedeon Richter Plc 53 Genes Involved 53 Insulin Pen 53 Contaminated Heparin 53 Insulin Delivery Devices 53 Receives Positive Opinion 53 Nanophase Announces 53 Proscape Technologies 53 Buys Majority Stake 53 Gets FDA Clearance 53 BioPartners 53 Licenses Novel 53 Drugmakers AstraZeneca 53 Develops Novel 53 Electrophysiology Mapping 52 Amgen Bayer Schering 52 Liquid Crystals 52 Dealmaking Profile 52 Bioanalysis 52 Pharmaxis ASX PXS 52 Interferon Alpha 52 Therapeutic Competitors Companies 52 Profit Growth Slows 52 IG HCR ;) CO 52 Centocor Schering Plough 52 Alnylam Pharma 52 Shows Efficacy 52 Therapeutic Competitors 52 Updates FY# EPS 52 MedPredict 52 OSI Pharma 52 Acquisition Strengthens 52 Pharma Biotech 52 Cardiac Assist Devices 52 Expands Internationally 52 Taisho Pharmaceuticals 52 Acne Drug 52 MedChem 52 Optimer Pharma 52 Majority Stake 52 ProChon Biotech 52 Cautious Outlook 52 Espicom Business Intelligence 52 Cancer Therapies 52 Taiho Pharmaceutical 52 Altana Pharma 52 Goes Hostile 52 Ionic Liquids 52 Volatile Session 52 Competitive Position 52 Diagnostic Imaging Devices 52 Generic Version Of 52 Cancer Immunotherapy 52 NYSE WYE 52 Takeover Talks 52 Neurotherapeutics 52 http:/www.presseportal.de 52 Synthetic Peptide 52 ZETIA ezetimibe 52 Metabolic Profiling 52 Patent Infringement Case 52 Newron Pharmaceuticals 52 Institutional Clients 52 FDA Approvals 52 Drug Approvals 52 Settles Patent Litigation 51 Biopharm 51 Protein Expression 51 Influenza Vaccine 51 Receives CE Marking 51 IND Filing 51 LTD YA 51 FDA Okays 51 Takeda Pharma 51 Outlook Darkens 51 Laboratory Glassware 51 Buying Spree 51 MorphoSys AG FSE MOR 51 Ticks Higher 51 Auxilium Pharma 51 Initiates Clinical Trial 51 Fresh Produce Portal 51 Biomarker Study 51 Merger Creates 51 Amlodipine Besylate 51 Cadila Health 51 Announces FDA Clearance 51 Receives Clearance 51 Affirms FY# 51 Remains Bullish 51 Protherics PLC announces 51 Biomarin 51 Biopharma 51 Takes Majority Stake 51 Proprietary Products 51 Tremendous Growth 51 Expanded Indication 51 Viatris 51 Heumann Pharma 51 Anti Tumor 51 Study Validates 51 Demonstrates Commitment 51 Bayer Yakuhin 51 Results Disappoint 51 Biotherapeutics 51 WILEX AG 51 www.roche.com 51 Indegene 51 Drug Pipeline 51 Shrs Fall 51 www.boehringer ingelheim.com 51 Drug Metabolism 51 Accelerates Growth 51 Kosan dependence 51 Confirms Commitment 51 Vascular Targeting Agents 51 BRILINTA 51 Small Molecule 51 Phase III Clinical Trials 51 Upcoming Webinar 51 Patent Lawsuit 51 Lowers FY# EPS 51 Migraine Treatment 51 Infectious Disease Testing 51 Novel Antibiotic 51 Antibody Therapeutics 51 Quark Biotech 51 Nasdaq CRXL 51 Cardiovascular Devices 51 Interest Rate Concern 51 OTC BB PVCT 51 Patent Filing 51 Immunosuppressant 51 BioElectronics Announces 51 Posts Modest 51 Survey Predicts 51 Therapeutic Monoclonal Antibodies 51 Central Venous Catheters 51 Diabetic Foot Ulcer 51 Anti infective 51 NASDAQ CRXL 51 Cefzil 51 Drug Makers 51 Penwest Pharma 51 segment Biotest 50 Present Preclinical Data 50 Study Shows Significant 50 Momenta Pharmaceuticals MNTA 50 Topiramate Tablets 50 EMD Biosciences Inc. 50 AurSCOPE 50 Deliver Powerful 50 Exchange Traded Derivatives 50 Outlook Dims 50 EU#.# Billion [002] 50 Solar Photovoltaic Market 50 Sanofi NYSE SNY 50 Asthma COPD 50 Not Disclosed 50 Gene Silencing 50 Protein Therapeutics 50 Patent Reexamination 50 Onyx Pharma 50 Expands Globally 50 Avidex 50 Launches Pioneering 50 DRAM Pricing 50 StockSource.us Reports USOG 50 Therapeutic Proteins 50 Transgenomic Pharmacogenomics Services 50 Glucose Monitoring 50 EpiTherapeutics 50 Antibody Discovery 50 @ crucell.com 50 EMD Biosciences 50 Achieves Record Sales 50 Patient Monitoring Market 50 Insulin Delivery 50 Endoscopy Devices 50 Patient Monitoring Devices 50 Receives FDA Clearance 50 Cancer Vaccine 50 Pharmacogenomic 50 Currency Majors Technical 50 Taro Receives 50 Presenter Profiles 50 Aciphex R 50 Further Strengthens 50 Hepatocellular Carcinoma 50 elbion 50 Tibotec Pharmaceuticals Ltd. 50 #.#B Bid 50 Investments Limited reg. 50 Vascular Wrap TM 50 Recombinant Protein 50 Recombinant Human 50 Daiichi Suntory Pharma 50 Bayer Yakuhin Ltd. 50 Trading Volumes 50 ImmunoCellular Therapeutics 50 Buyout Firms 50 Antibacterials 50 Hostile Bid 50 ASX PGL 50 Graffinity Pharmaceuticals 50 Syntonix Pharmaceuticals 50 Isis Pharma 50 Phase 2a Trial 50 Antipsychotic Drug 50 Cardiovascular Prosthetic Devices 50 High Growth Forecasted 50 Exploratory Clinical 50 Strengthens Leadership 50 Ridaforolimus 50 Teva Provides Update 50 Hiring Spree 50 PDUFA Date 50 Molecular Diagnostic 50 Sees Slower Growth 50 Presents Preclinical Data 50 Announces Rebranding 50 Transdermal Delivery 50 Pandemic Influenza Vaccines 50 MarketResearch.com Announces 50 Consulting Fees Honoraria 50 Roche OTC RHHBY 50 Heart Stents 50 Kidney Transplant Patients 50 Amira Pharmaceuticals 50 www.ucb group.com 50 Grows Rapidly 50 Clinical Diagnostics 50 AM Vitals 50 Arthritis Drugs 50 Bone Grafts 50 Idera Pharmaceuticals 50 Boehringer Ingelheim Bristol Myers 50 Small Molecule Drug 50 Settles Patent Infringement Lawsuit 50 Generic Drug 50 Windhover Conferences 50 Custom Synthesis 50 Vaccinogen 50 Terbinafine 50 Granted Orphan Drug 50 Anticancer Agent 50 M.D. Ph.D. 50 Acute Pain 50 Inks Deals 49 Commences Phase III 49 Genedata 49 Begins Clinical Trial 49 AbD Serotec 49 Cancer Biomarker 49 Accelerates Expansion 49 Device Maker 49 Pharmaceuticals Initiates 49 Biologics Manufacturing 49 Receives Regulatory Approvals 49 Cautious Optimism 49 Finacea 49 www.sedo.com 49 Trastuzumab DM1 49 Report Assesses 49 Lowers Profit 49 BioPharmaceutical 49 XPEL Announces 49 Antidepressant Drug 49 Max Neeman International 49 Counterfeit Drugs 49 Transdermal Patch 49 Pft Taking 49 Less Than Forecast 49 Pink Sheets RHHBY 49 Aarkstore 49 Immunochemistry 49 Patent Upheld 49 Stada Arzneimittel 49 Selvita 49 Orbimed Advisors LLC 49 Mitral Valve Repair 49 Continues Aggressive Growth 49 Networking Sites 49 Novel Therapies 49 Interest Rate Speculation 49 ESBATech AG 49 Viralytics 49 Protein Biomarker 49 Oligonucleotides 49 Novartis Ophthalmics 49 Expanding Presence 49 Bioprocess 49 Initiate Clinical Trial 49 Inflation Worries 49 DecisionSite 49 Biodefense Vaccines 49 Misonix Announces 49 Drug Coated Stent 49 Shareholder Opposes 49 CellMed 49 Avian Flu Vaccine 49 Directors Dealings 49 Ceflatonin R 49 Immunotherapies 49 Multicenter Phase 49 Salix Pharma 49 InNexus Biotechnology 49 Markets Plunge 49 Genetic Testing 49 Initiates Phase 2b 49 Maleate 49 Tightening Concerns 49 Makes Strides 49 Berlex Biosciences 49 www.paintrials.com 49 Safinamide 49 Merger Talks 49 Pierre Fabre SA 49 Saegis Pharmaceuticals 49 Clinical Trials 49 SUTENT ® 49 Therapeutic Antibodies 49 Tissue Regeneration 49 Clinphone 49 Surgical Equipment 49 Bioresorbable 49 URCH Publishing 49 GlycArt 49 Named Successor 49 Systemic Delivery 49 Subprime Losses 49 Capgemini BPO 49 Relsys 49 Infusion Pumps 49 Bln Bid 49 BioElectronics Corporation Announces 49 Packaging Materials 49 Sustained Release 49 Taiwanese Cable Modem 49 http:/www.gene.com/ 49 Takeover Approach 49 Patent Infringement Lawsuit 49 Analytical Tool 49 Cardiac Rhythm 49 Ophthalmics 49 Gene Synthesis 49 Veterinary Vaccines 49 Sees Challenging 49 Ownership Structure 49 Dr. Cauwenbergh 49 Stromedix 49 Liprotamase 49 Analgesics 49 Teleconf 49 Bazedoxifene 49 AstraZeneca AZN.L 行情 49 Fresenius Biotech 49 Napo Pharmaceuticals 49 Clinical Outcome 49 Catalyst Biosciences 49 MedManage 49 Announce Launch 49 Patent Covering 49 NASDAQ PCYC Niusule 49 Cancer Treatments 49 Sees Slower 49 Strand Genomics 49 Global Generics 48 PharmaDerm 48 SOLVAY PHARMACEUTICALS 48 Multi Faceted 48 Wound Closure Devices 48 Pazopanib 48 Presents Preclinical 48 HELSINN 48 Synthes GmbH 48 PanGenetics 48 Roopesh Patel 48 Finalize Merger 48 Novartis Pharma 48 Reverses Loss 48 Pharma Ingredients 48 Wins Patent Infringement 48 Biogen Elan 48 Valeant Pharma 48 Mersana Therapeutics Inc. 48 Seen Slowing 48 Drug Eluting 48 Westwicke Partners 48 Santhera Pharmaceuticals 48 Sandoz Novartis 48 Anticancer Drug 48 star.edu.sg 48 Completes Dosing 48 Concentrating Solar 48 Dexilant 48 See CLINICAL PHARMACOLOGY 48 Backs FY# 48 Pharmacovigilance 48 pharma.com 48 www.crucell.com 48 Pharmacology Toxicology 48 Pfizer Discontinues 48 Alapis SA 48 Summarizes 48 Aruvian R'search presents 48 Bayhill Therapeutics 48 Insulin Pumps 48 Incontinence Products 48 Cardiovascular Devices Market 48 Techpool 48 Anti CD# Antibody 48 Stocks Rise Amid 48 www.bms.com 48 www.syntapharma.com 48 Clinical Trial 48 Lab Automation 48 Oxytrol R 48 Experts Convene 48 Paladin Labs 48 Stronger Warnings 48 Joins Medidata Solutions 48 IMS MIDAS 48 Interest Rate Increases 48 Sells Itself 48 Antibody Engineering 48 http:/www.shire.com 48 GlaxoSmithKline Coreg 48 Patent Litigation 48 Biodegradable Polymers 48 Newsflow 48 Risk Appetite Returns 48 Hormonal Contraceptives 48 ICANN Approves 48 Metabolic Endocrinology 48 Schizophrenia Treatment 48 Zegerid OTC 48 Levocetirizine 48 Cosmeceutical 48 PregLem 48 Atopic Dermatitis 48 Chipscreen Biosciences 48 Synovate Healthcare 48 Easing Inflation 48 generic injectables 48 Liquent 48 FTC Clears 48 Quotient Bioresearch 48 Clinical Therapies Endoscopy 48 Pharmacueticals 48 mtm laboratories 48 BioFocus DPI Galapagos 48 Genelabs Technologies 48 Shareholder Suits 48 Wall Street Fluctuates 48 Merrion Pharmaceuticals 48 Orally Disintegrating 48 Oxford Genome Sciences 48 Person Says Update1 48 Wound Closure 48 Novel Therapeutics 48 @ dsm.com 48 Attract Buyers 48 Ortho Cept 48 Preclinical Models 48 Exclusive License 48 Interest Rate Increase 48 Kinase Inhibitor 48 Radiopharmaceutical 48 Generics 48 Specialised Therapeutics 48 Oroco Announces 48 Patient Recruitment 48 Crucell NV Euronext 48 SHP.L 48 Biopharmaceutical Manufacturing 48 www.cegedim.com 48 Nasdaq IPXL 48 Exec Sees 48 Generic Pharmaceutical 48 Sees Significant 48 Extends Relationship With 48 Lixisenatide 48 Antiviral Therapeutics 48 Jointly Launch 48 Implementing Successful 48 Stronger Yuan 48 Integra LifeSciences Announces 48 BioPharma 48 Astex Therapeutics Limited 48 gets USFDA nod 48 Illiquid Assets 48 Fougera 48 +#- 0 #-# [001] 48 FDAnews 48 Bionanotechnology 48 Sharpens Focus 48 Roche Boniva 48 Avian Influenza Vaccine 48 Pharmatech 48 Molecular Diagnostics 48 Piramed 48 Stapled Peptide 48 Oral Suspension USP 48 Astellas Pharmaceuticals 48 Outlook Gloomy 48 Textile Fibers 48 www.vioquestpharm.com 48 Drug Delivery 48 Sees Increased 48 Resubmission 48 Stocks Rise Sharply 48 Patent Dispute 48 & Sullivan http:/www.pharma.frost.com 48 Internet http:/www.presseportal.de 48 Experiences Significant 48 Stocks Rise Slightly 48 Pharmaceutical 48 pharmacogenomic translational research 48 Antifungals 48 Microwave Ablation System 48 Pipeline Analysis 48 Sustain Growth 48 Nippon Shinyaku 48 Teva Pharma 48 ICON plc 48 Helsinn 48 Omacor ® 48 Wide Ranging 48 Epidemiological Studies Unit 48 Converged Device 48 Vitro Diagnostics 48 Veregen 48 RNCOS Releases New 48 Teva Pharm 48 Anticalin R 48 Plastic Closures 48 Ingenuity Systems 48 Silicone Breast Implant 48 AGI Therapeutics 48 Survey Conducted 47 Neurostimulation Devices 47 FDC Windhover 47 Receives ISO #:# [002] 47 KIKA Clinical Solutions 47 Bone Metastases 47 KAI Pharmaceuticals 47 Intellectual Property Portfolio 47 Merck Serono Ventures 47 Drug Discovery 47 PHARMACEUTICALS 47 Index SPI SPIEX 47 Antitrust Probe 47 Merck KgaA 47 Orexo AB 47 Investors Await Fed 47 Respiratory Disorders 47 Strengthen Relationship 47 Adaptive Clinical Trials 47 Implantable Device 47 Companion Diagnostics 47 Yuan Revaluation 47 Joins Chadbourne & 47 SynCo Bio Partners 47 Zikria Syed CEO 47 Latest Developments 47 Biostatistical 47 Supernus Pharmaceuticals Inc. 47 BioWorld Today 47 Obtains Exclusive License 47 Differentiator 47 Pharma 47 Traversa Therapeutics 47 Slips Slightly 47 Proxy Proposals 47 Volatile Trading 47 Medigene 47 Fixed Income Derivatives 47 Bayer Schering 47 Wound Dressing 47 Inovio Pharmaceuticals 47 Takeover Targets 47 Cilag 47 Excel PharmaStudies 47 Spinal Implant 47 Confirms Validity 47 Axxam 47 Benign Prostatic Hyperplasia 47 Merger Approved 47 Alexion Soliris 47 Ventures Invests 47 ALK Abelló 47 http:/www.BMRN.com 47 Inspire Pharma 47 Oasmia 47 Spray Drying 47 Receptor Agonist 47 www.cdexinc.com 47 Sell Offs 47 Stocks Stumble 47 Veregen R 47 JAK Inhibitor 47 Jiangbo Pharmaceuticals 47 Biomarker 47 Organon Pharmaceuticals 47 Referenced EEG 47 Strategic Insights 47 Orthopedic Biomaterials 47 Silicone Breast Implants 47 Osteoporosis Treatment 47 plc SWOT Analysis 47 cro.com 47 Nasdaq AVNC 47 BR# Northern Trust 47 M &A; 47 Ascent Therapeutics 47 Finanz und 47 MindUp BioResearch 47 Orthopedic Musculoskeletal Devices 47 Pharmaceuticals Impax 47 FDA Approval 47 www.shire.com 47 Pending Acquisition 47 Expandable Polystyrene 47 Worker Shortage 47 Capsulution 47 Addresses Challenges 47 Biosimilar 47 Terminally Ill Patients 47 Risky Assets 47 Acute Heart Failure 47 Chugai Pharma USA 47 Pharma AG 47 Replagal TM 47 CNS Therapeutics 47 BioDelivery Sciences 47 KINAXO 47 Synergyst 47 Synageva BioPharma Corp. 47 Veeva Systems 47 Antiviral Drug 47 Kyowa Hakko Kogyo 47 Tibotec 47 Kissei Pharmaceutical 47 www.bayerhealthcare.com 47 Helsinn Healthcare 47 Settle Patent 47 Meditrina Pharmaceuticals 47 http:/www.reprosrx.com 47 Cut Carbon Emissions 47 Celgene Thalomid 47 Loramyc 47 Therapeutic Areas 47 SAR# [002] 47 Diagnostic Tools 47 Cardiotoxicity 47 Private Equity Buyout 47 Vascular Targeting 47 Offers Customized 47 Chartpoppers.com releases Investment 47 Inhaled Liposomal Ciprofloxacin 47 Genentech Biogen Idec 47 Key Competitors 47 Xarelto rivaroxaban 47 Ratings Downgrade 47 Growth Exceeds Expectations 47 Execs Discuss 47 Nichi iko 47 Injectable Drug 47 Cubist Pharma 47 Immunotherapeutics 47 Buyout Talks 47 Inpharmatica 47 Lifescience 47 Drug Repositioning 47 Supply Glut 47 MerLion Pharmaceuticals 47 TKPHF 47 Retains CCG Elite 47 Ardea Biosciences 47 Detailed Product 47 Achieves ISO #:# Certification [002] 47 Source Victhom Human 47 Exclusive Licensee 47 Announce Expanded 47 ATLN 47 PAION AG ISIN 47 Loramyc ™ 47 sanofi 47 Algos 47 Clinical Trial Data 47 Transcatheter Valve 47 GIPET 47 Ipsen SA 47 Authorized Generics 47 Sees Substantial 47 novel oral anticoagulant 47 Solar Wafer 47 Stockwire.com OTC 47 CCID Consulting Analyzes 47 www.BMRN.com 47 NOVN 47 Orthopedic Devices Market 47 Growing Rapidly 47 Tibotec Pharmaceuticals 47 Antisense Pharma GmbH 47 Mylan Nasdaq MYL 47 Obtains CE Mark 47 SICOR 47 Sell Majority Stake 47 Cardiovascular Metabolic 47 Meiji Seika 47 Measured Approach 47 Reinforces Leadership 47 Small Molecules 47 Movianto 47 ir@crucell.com www.crucell.com 47 Stocks Rise Moderately 47 http:/www.dynavax.com 47 http:/www.lilly.com 47 Sweetens Offer 47 Oral Insulin 47 Prolexys 47 Ascenta Therapeutics 47 ratiopharm 47 Pharmaprojects 47 Lupin Pharmaceuticals 47 Potash Bid 47 Wound Care Markets 47 Regenerative Cells 47 Integra Lifesciences 47 Legacy Modernization 47 Trauma Fixation 47 Slower Growth 47 Application Outsourcing 47 Febuxostat 47 ChinaBio ® 47 Pandel R 47 Non Invasive 47 www.gene.com 47 Otsuka Pharmaceutical 46 Zydus Pharmaceuticals 46 Tumor Targeting 46 Medpharm 46 XTL Biopharmaceuticals 46 http:/www.pharmacopeia.com 46 CNS Disorders 46 Sankyo Pharma Inc. 46 Circ Pharma 46 Midafternoon Trading 46 Novartis AG NOVN.VX 46 Marketed Products 46 Afferent Pharmaceuticals 46 Biogenerics 46 www.sigma 46 Epiphany Biosciences 46 Ophthalmic Drug 46 www.maxygen.com 46 Glaxo SmithKline GSK 46 Cerimon Pharmaceuticals Inc. 46 ONCONASE ranpirnase 46 epoetin zeta 46 Monoclonal Antibodies 46 Drug Resistant Tuberculosis 46 Vifor Pharma 46 Supernus Pharmaceuticals 46 Stakeholder Opinions 46 Sleep Apnea Diagnostic 46 www.HirschElectronics.com 46 Activity Slows 46 Biochip 46 Crucell NV NASDAQ CRXL 46 Phytomedics Inc. 46 cosmetic cosmeceutical products 46 Authorized Generic 46 Multiparameter Patient Monitoring 46 Invites Nominations 46 Nasdaq MDSO 46 RELOVAIR ™ 46 Structured Cabling Systems 46 Currency Revaluation 46 ERYtech 46 Rückfragehinweis 46 www.cticseattle.com 46 Jeffrey Holford 46 Merck Serono 46 Gastrointestinal Stromal Tumors 46 Quotient Biodiagnostics 46 TrialWorks 46 Maven Semantic http:/www.mavensemantic.com announBruising Brandon 46 http:/www.bms.com 46 Breast Implant 46 www.quintiles.com 46 Hematopoietic Stem Cell Transplantation 46 Idenix Pharmaceuticals 46 Theranostics 46 i3 Statprobe 46 Oxford BioTherapeutics 46 Expand Scope 46 Orthopaedics Endoscopy 46 Bayer Schering Pharma 46 Regulatory Requirements 46 Sources NASDAQ GSOL 46 Glatiramer Acetate 46 NorDiag 46 Rapidly Expands 46 Intendis 46 Neurimmune 46 Macroeconomic Policy 46 Merck KGaA Darmstadt Germany 46 Mergers Acquisitions 46 Quotient Clinical 46 Stays Strong 46 Diagnostic Tests 46 Merger Discussions 46 Covalys 46 Competitive Pressures 46 Anti infectives 46 http:/www.openwave.com 46 ERYtech Pharma 46 Maximize Shareholder Value 46 Cmed 46 Schering SHR 46 Actelion Pharmaceuticals Ltd 46 Fukuda Denshi 46 Debt Offerings 46 Randomized Clinical Trials 46 Macro Trends 46 invivodata inc 46 Drug Eluting Coronary Stent 46 Subprime Woes 46 #-#-# x# Email 46 Hosting Firm 46 Enters Into Collaboration 46 Regulatory Hurdles 46 Anti Viral 46 HerbalScience 46 Otsuka Pharmaceuticals 46 providers Adis 46 includes Dideco CarboMedics 46 Nonprescription 46 Exec Quits 46 Vivecon 46 Insulin Delivery Systems 46 Upcoming Investor 46 Drug Interactions 46 Generex Biotechnology 46 Temperature Monitoring Devices 46 Forays Into 46 Glaxo Sanofi 46 DAYTRANA TM 46 Biotech Pharma 46 Billion Takeover 46 Warfarin Coumadin 46 Selects BoardVantage 46 Bulks Up 46 External Defibrillators 46 Oxcarbazepine 46 Structural Changes 46 5EU 46 Pepscan Therapeutics 46 SkyePharma Plc 46 Issued Patent 46 NavCom Technology 46 Xenoport Inc. 46 Ergomed 46 Investor Relations tel 46 Ambrisentan 46 Speedel Holding AG 46 +#-#-#-# @ thomson.com 46 Stem Cell Treatment 46 Sees Robust 46 Novartis Sandoz 46 Spinal Implants 46 RNA Interference 46 Patents Covering 46 RNCOS Releases Report 46 Peripheral Vascular Devices 46 Archexin 46 Sunovion 46 Technological Advances 46 Increases Commitment 46 Merz Pharma GmbH 46 Biotech 46 Antisense Pharma 46 Nycomed 46 www.sanofi aventis.com 46 categories Glucose Monitoring 46 www.austriamicrosystems.com 46 Pluristem Therapeutics 46 MerLion 46 Ecron Acunova 46 http:/www.gsk.com 46 Arrow Electronics Acquires 46 Boehringer Ingelheim GmbH 46 Biopharmaceuticals 46 Novel Therapeutic